FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne Gershon

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Co-author Network

Publications

TOP 3
Anne A Gershon
Varicella zoster vaccines and their implications for development of HSV vaccines.
Anne A Gershon
The history and mystery of VZV in saliva.
Eugene D Shapiro; Marietta Vazquez; Daina Esposito; Nancy Holabird; Sharon P Steinberg; James Dziura; Philip S LaRussa; Anne A Gershon
Effectiveness of 2 doses of varicella vaccine in children.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne Gershon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anne A Gershon
Varicella zoster vaccines and their implications for development of HSV vaccines.
Virology 2013;435(1):29-36.
2011: Anne A Gershon
The history and mystery of VZV in saliva.
The Journal of infectious diseases 2011;204(6):815-6.
2011: Eugene D Shapiro; Marietta Vazquez; Daina Esposito; Nancy Holabird; Sharon P Steinberg; James Dziura; Philip S LaRussa; Anne A Gershon
Effectiveness of 2 doses of varicella vaccine in children.
The Journal of infectious diseases 2011;203(3):312-5.
2010: Moeun Son; Eugene D Shapiro; Philip S LaRussa; Natalie Neu; David E Michalik; Michelle Meglin; Andrea Jurgrau; Wally Bitar; Marietta Vasquez; Patricia Flynn; Anne A Gershon
Effectiveness of varicella vaccine in children infected with HIV.
The Journal of infectious diseases 2010;201(12):1806-10.
2010: Anne A Gershon; Michael D Gershon; Judith Breuer; Myron J Levin; Anne Louise Oaklander; Paul D Griffiths
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;48 Suppl 1():S2-7.
2010: Adriana Weinberg; Ann A Lazar; Gary O Zerbe; Anthony R Hayward; Ivan S F Chan; Rupert Vessey; Jeffrey L Silber; Rob R MacGregor; Kenny Chan; Anne A Gershon; Myron J Levin
Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.
The Journal of infectious diseases 2010;201(7):1024-30.
2010: Anne A Gershon; Michael D Gershon
Perspectives on vaccines against varicella-zoster virus infections.
Current topics in microbiology and immunology 2010;342():359-72.
2010: Michael D Gershon; Anne A Gershon
VZV infection of keratinocytes: production of cell-free infectious virions in vivo.
Current topics in microbiology and immunology 2010;342():173-88.
2010: Anne A Gershon
Vaccination against varicella: what's the point?
Advances in experimental medicine and biology 2010;659():83-7.
2009: Anne A Gershon; Myron J Levin; Adriana Weinberg; Lin-Yee Song; Philip S LaRussa; Sharon P Steinberg; Patterson Bartlett
A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
The Pediatric infectious disease journal 2009;28(7):653-5.
2008: David E Michalik; Sharon P Steinberg; Philip S LaRussa; Kathryn M Edwards; Peter F Wright; Ann M Arvin; Haley A Gans; Anne A Gershon
Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
The Journal of infectious diseases 2008;197(7):944-9.
2008: Anne A Gershon; Jason Chen; Michael D Gershon
A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons.
The Journal of infectious diseases 2008;197 Suppl 2():S61-5.
2008: Anne A Gershon; Ann M Arvin; Myron J Levin; Jane F Seward; D Scott Schmid
Varicella vaccine in the United States: a decade of prevention and the way forward.
The Journal of infectious diseases 2008;197 Suppl 2():S39-40.
2008: Anne A Gershon; Samuel L Katz
Perspective on live varicella vaccine.
The Journal of infectious diseases 2008;197 Suppl 2():S242-5.
2008: Sophie Hambleton; Sharon P Steinberg; Philip S LaRussa; Eugene D Shapiro; Anne A Gershon
Risk of herpes zoster in adults immunized with varicella vaccine.
The Journal of infectious diseases 2008;197 Suppl 2():S196-9.
2008: Susan A Galea; Ann Sweet; Paul Beninger; Sharon P Steinberg; Philip S LaRussa; Anne A Gershon; Robert G Sharrar
The safety profile of varicella vaccine: a 10-year review.
The Journal of infectious diseases 2008;197 Suppl 2():S165-9.
2008: Anne A Gershon
Varicella-zoster virus infections.
Pediatrics in review / American Academy of Pediatrics 2008;29(1):5-10; quiz 11.
2007: Patrick Jean-Philippe; Abigail Freedman; Mary Wu Chang; Sharon P Steinberg; Anne A Gershon; Philip S LaRussa; William Borkowsky
Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction.
Pediatrics 2007;120(5):e1345-9.
2007: Judith Breuer; Mark Quinlivan; Mahmoud Al Bassam; Susannah Macdonald; Richard A Nichols; Sharon P Steinberg; Philip La Russa; Anne A Gershon
DNA sequence variability in Oka vaccine isolates.
The Journal of infectious diseases 2007;196(5):801-2; author reply 802-3.
2007: Sophie Hambleton; Sharon P Steinberg; Michael D Gershon; Anne A Gershon
Cholesterol dependence of varicella-zoster virion entry into target cells.
Journal of virology 2007;81(14):7548-58.
2007: Mark Quinlivan; Anne A Gershon; Mahmoud M Al Bassam; Sharon P Steinberg; Philip S LaRussa; Richard A Nichols; Judith Breuer
Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(1):208-12.
2006: Ann M Arvin; Anne A Gershon
Control of varicella: why is a two-dose schedule necessary?
The Pediatric infectious disease journal 2006;25(6):475-6.
2006: Mark A Quinlivan; Anne A Gershon; Richard A Nichols; Philip La Russa; Sharon P Steinberg; Judith Breuer
Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
The Journal of infectious diseases 2006;193(7):927-30.
2006: Christina L Stallings; Gregory J Duigou; Anne A Gershon; Michael D Gershon; Saul J Silverstein
The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.
Journal of virology 2006;80(3):1497-512.
2005: Sophie Hambleton; Anne A Gershon
The impact of varicella vaccination in the United States.
Seminars in pediatric infectious diseases 2005;16(1):38-43.
2005: Sophie Hambleton; Anne A Gershon
Preventing varicella-zoster disease.
Clinical microbiology reviews 2005;18(1):70-80.
2005: Anne A Gershon
Contagiousness of varicella in vaccinated cases: a household contact study.
The Journal of pediatrics 2005;146(1):147.
2005: Mark Quinlivan; Anne A Gershon; Sharon P Steinberg; Judith Breuer
An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
Journal of medical virology 2005;75(1):174-80.
2004: Jason Jingxian Chen; Zhenglun (Jerry) Zhu; Anne A Gershon; Michael D Gershon
Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster.
Cell 2004;119(7):915-26.
2004: Sophie Hambleton; Michael D Gershon; Anne A Gershon
The role of the trans-Golgi network in varicella zoster virus biology.
Cellular and molecular life sciences : CMLS 2004;61(24):3047-56.
2004: Anne A Gershon; Sophie Hambleton
Varicella vaccine for susceptible adults: do it today.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(11):1640-1.
2004: Mark Quinlivan; Anne A Gershon; Sharon P Steinberg; Judith Breuer
Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
The Journal of infectious diseases 2004;190(4):793-6.
2004: Marietta Vázquez; Philip S LaRussa; Anne A Gershon; Linda M Niccolai; Catherine E Muehlenbein; Sharon P Steinberg; Eugene D Shapiro
Effectiveness over time of varicella vaccine.
JAMA : the journal of the American Medical Association 2004;291(7):851-5.
2003: Jason Jingxian Chen; Anne A Gershon; Zhi Shan Li; Octavian Lungu; Michael D Gershon
Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus.
Journal of medical virology 2003;70 Suppl 1():S71-8.
2002: Anne A Gershon; Stephen E Straus
Samuel L. Katz: pioneer in development of and international advocate for vaccines.
Seminars in pediatric infectious diseases 2002;13(3):221-31.
2002: Krow Ampofo; Lisa Saiman; Philip S LaRussa; Sharon Steinberg; Paula Annunziato; Anne A Gershon
Persistence of immunity to live attenuated varicella vaccine in healthy adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(6):774-9.
2001: Anne A Gershon
Prevention and treatment of VZV infections in patients with HIV.
Herpes : the journal of the IHMF 2001;8(2):32-6.
2001: Lisa Saiman; Philip S LaRussa; Sharon P Steinberg; Juyan Zhou; K Baron; Susan Whittier; Phyllis Della-Latta; Anne A Gershon
Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2001;22(5):279-83.
2001: Marietta Vázquez; Philip S LaRussa; Anne A Gershon; Sharon P Steinberg; Kimberly A Freudigman; Eugene D Shapiro
The effectiveness of the varicella vaccine in clinical practice.
The New England journal of medicine 2001;344(13):955-60.
2001: Anne A Gershon
Live-attenuated varicella vaccine.
Infectious disease clinics of North America 2001;15(1):65-81, viii.
2001: Philip S LaRussa; Anne A Gershon
Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates.
Archives of virology. Supplementum 2001;(17):41-8.
2001: Anne A Gershon
The current status of live attenuated varicella vaccine.
Archives of virology. Supplementum 2001;(17):1-6.
2001: Z H Wang; Michael D Gershon; Octavian Lungu; Zhenglun (Jerry) Zhu; S Mallory; Ann M Arvin; Anne A Gershon
Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument.
Journal of virology 2001;75(1):323-40.
2000: Philip S LaRussa; Sharon P Steinberg; E Shapiro; M Vazquez; Anne A Gershon
Varicella vaccine revisited.
Nature medicine 2000;6(12):1299-300.
2000: Robert G Sharrar; Philip S LaRussa; S A Galea; Sharon P Steinberg; A R Sweet; R M Keatley; M E Wells; W P Stephenson; Anne A Gershon
The postmarketing safety profile of varicella vaccine.
Vaccine 2000;19(7-8):916-23.
2000: Philip S LaRussa; Sharon P Steinberg; E Shapiro; M Vazquez; Anne A Gershon
Viral strain identification in varicella vaccinees with disseminated rashes.
The Pediatric infectious disease journal 2000;19(11):1037-9.
2000: Z H Wang; Michael D Gershon; Octavian Lungu; Zhenglun (Jerry) Zhu; Anne A Gershon
Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain.
Journal of virology 2000;74(14):6600-13.
2000: Paula Annunziato; Octavian Lungu; CA Panagiotidis; J H Zhang; David N Silvers; Anne A Gershon; Saul J Silverstein
Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox.
Journal of virology 2000;74(4):2005-10.
1999: S Kohl; J Rapp; P La Russa; Anne A Gershon; Sharon P Steinberg
Natural varicella-zoster virus reactivation shortly after varicella immunization in a child.
The Pediatric infectious disease journal 1999;18(12):1112-3.
1999: Michael D Gershon; Anne A Gershon
Role of glycoproteins in varicella-zoster virus infection.
Contributions to microbiology 1999;3():43-60.
1998: Anne A Gershon
Varicella: to vaccinate or not to vaccinate?
Archives of disease in childhood 1998;79(6):470-1.
1998: Philip S LaRussa; Sharon Steinberg; Ann M Arvin; D Dwyer; M Burgess; M Menegus; K Rekrut; K Yamanishi; Anne A Gershon
Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.
The Journal of infectious diseases 1998;178 Suppl 1():S64-6.
1998: Paula Annunziato; Philip S LaRussa; P Lee; Sharon Steinberg; Octavian Lungu; Anne A Gershon; Saul Silverstein
Evidence of latent varicella-zoster virus in rat dorsal root ganglia.
The Journal of infectious diseases 1998;178 Suppl 1():S48-51.
1998: Z Wang; Michael D Gershon; Octavian Lungu; CA Panagiotidis; Zhenglun (Jerry) Zhu; Y Hao; Anne A Gershon
Intracellular transport of varicella-zoster glycoproteins.
The Journal of infectious diseases 1998;178 Suppl 1():S7-12.
1998: A Derryck; Philip S LaRussa; Sharon Steinberg; M Capasso; Jane Pitt; Anne A Gershon
Varicella and zoster in children with human immunodeficiency virus infection.
The Pediatric infectious disease journal 1998;17(10):931-3.
1998: X T Ussery; Paula Annunziato; Anne A Gershon; B S Reid; Octavian Lungu; C Langston; Saul Silverstein; K K Lee; Carol J Baker
Congenital varicella-zoster virus infection and Barrett's esophagus.
The Journal of infectious diseases 1998;178(2):539-43.
1998: Octavian Lungu; CA Panagiotidis; Paula Annunziato; Anne A Gershon; Saul J Silverstein
Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(12):7080-5.
1998: Anne A Gershon; Philip S LaRussa
Varicella vaccine.
The Pediatric infectious disease journal 1998;17(3):248-9.
1997: Anne A Gershon; N Mervish; Philip S LaRussa; Sharon Steinberg; Shaw-Hwa Lo; D Hodes; S Fikrig; Vincent Bonagura; S Bakshi
Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.
The Journal of infectious diseases 1997;176(6):1496-500.
1997: Anne A Gershon; Pierce Gardner; G Peter; K Nichols; Walter A Orenstein
Quality standards for immunization. Guidelines from the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(4):782-6.
1997: Philip S LaRussa; Sharon Steinberg; Francois Meurice; Anne A Gershon
Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts.
The Journal of infectious diseases 1997;176(4):1072-5.
1997: Janet A Englund; Carol J Baker; Claire Raskino; Ross E McKinney; B Petrie; Mary Glenn Fowler; D Pearson; Anne A Gershon; George McSherry; Elaine J Abrams; J Schliozberg; John L Sullivan
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
The New England journal of medicine 1997;336(24):1704-12.
1997: Anne A Gershon; Saul Silverstein
Live attenuated varicella vaccine for prevention of herpes zoster.
Biologicals : journal of the International Association of Biological Standardization 1997;25(2):227-30.
1997: Henry M Feder; Philip S LaRussa; Sharon Steinberg; Anne A Gershon
Clinical varicella following varicella vaccination: don't be fooled.
Pediatrics 1997;99(6):897-9.
1996: Paula Annunziato; Anne A Gershon
Herpes simplex virus infections.
Pediatrics in review / American Academy of Pediatrics 1996;17(12):415-23; quiz 424.
1996: Paula Annunziato; Octavian Lungu; Anne A Gershon; David N Silvers; Philip S LaRussa; Saul J Silverstein
In situ hybridization detection of varicella zoster virus in paraffin-embedded skin biopsy samples.
Clinical and diagnostic virology 1996;7(2):69-76.
1996: Philip S LaRussa; Sharon Steinberg; Anne A Gershon
Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada.
The Journal of infectious diseases 1996;174 Suppl 3():S320-3.
1996: Zhenglun (Jerry) Zhu; Y Hao; Michael D Gershon; Richard T Ambron; Anne A Gershon
Targeting of glycoprotein I (gE) of varicella-zoster virus to the trans-Golgi network by an AYRV sequence and an acidic amino acid-rich patch in the cytosolic domain of the molecule.
Journal of virology 1996;70(10):6563-75.
1996: Anne A Gershon; Philip S LaRussa; Sharon Steinberg
The varicella vaccine. Clinical trials in immunocompromised individuals.
Infectious disease clinics of North America 1996;10(3):583-94.
1996: Anne A Gershon
Epidemiology and management of postherpetic neuralgia.
Seminars in dermatology 1996;15(2 Suppl 1):8-13.
1996: Anne A Gershon
More questions about varicella vaccination.
The Pediatric infectious disease journal 1996;15(6):560-1.
1996: Anne A Gershon; Philip S LaRussa; Sharon Steinberg; N Mervish; Shaw-Hwa Lo; P Meier
The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox.
The Journal of infectious diseases 1996;173(2):450-3.
1995: Zhenglun (Jerry) Zhu; Michael D Gershon; C Gabel; D Sherman; Richard T Ambron; Anne A Gershon
Entry and egress of varicella-zoster virus: role of mannose 6-phosphate, heparan sulfate proteoglycan, and signal sequences in targeting virions and viral glycoproteins.
Neurology 1995;45(12 Suppl 8):S15-7.
1995: Zhenglun (Jerry) Zhu; Michael D Gershon; Y Hao; Richard T Ambron; C A Gabel; Anne A Gershon
Envelopment of varicella-zoster virus: targeting of viral glycoproteins to the trans-Golgi network.
Journal of virology 1995;69(12):7951-9.
1995: Octavian Lungu; Paula Annunziato; Anne A Gershon; S M Staugaitis; D Josefson; Philip S LaRussa; Saul J Silverstein
Reactivated and latent varicella-zoster virus in human dorsal root ganglia.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(24):10980-4.
1995: Anne A Gershon
Development of live attenuated varicella vaccine.
Proceedings of the Association of American Physicians 1995;107(3):365-8.
1995: Anne A Gershon
Varicella vaccine: its past, present and future.
The Pediatric infectious disease journal 1995;14(9):742-4.
1995: Anne A Gershon
Present and future challenges of immunizations on the health of our patients.
The Pediatric infectious disease journal 1995;14(5):445-9.
1995: Zhenglun (Jerry) Zhu; Michael D Gershon; Richard T Ambron; C Gabel; Anne A Gershon
Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(8):3546-50.
1995: F Blaine Hollinger; T Eickhoff; Anne A Gershon; E C Jong; R S Koff
Discussion: who should receive hepatitis A vaccine? A strategy for controlling hepatitis A in the United States.
The Journal of infectious diseases 1995;171 Suppl 1():S73-7.
1995: Anne A Gershon
Varicella-zoster virus: prospects for control.
Advances in pediatric infectious diseases 1995;10():93-124.
1994: Anne A Gershon; D L Sherman; Zhenglun (Jerry) Zhu; C A Gabel; Richard T Ambron; Michael D Gershon
Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network.
Journal of virology 1994;68(10):6372-90.
1994: Anne A Gershon; Philip S LaRussa; S Steinberg
Detection of antibodies to varicella-zoster virus using a latex agglutination assay.
Clinical and diagnostic virology 1994;2(4-5):271-7.
1994: P Hughes; Philip S LaRussa; J M Pearce; M Lepow; Sharon Steinberg; Anne A Gershon
Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction.
The Journal of pediatrics 1994;124(6):932-5.
1993: Anne A Gershon
Immunizations for pediatric transplant patients.
Kidney international. Supplement 1993;43():S87-90.
1992: Anne A Gershon; Philip S LaRussa; I Hardy; Sharon Steinberg; Saul Silverstein
Varicella vaccine: the American experience.
The Journal of infectious diseases 1992;166 Suppl 1():S63-8.
1992: Anne A Gershon
Varicella vaccine: still at the crossroads.
Pediatrics 1992;90(1 Pt 2):144-8.
1992: Philip S LaRussa; Octavian Lungu; I Hardy; Anne A Gershon; S P Steinberg; Saul Silverstein
Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.
Journal of virology 1992;66(2):1016-20.
1991: I Hardy; Anne A Gershon; S P Steinberg; Philip S LaRussa
The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
The New England journal of medicine 1991;325(22):1545-50.
1991: Anne A Gershon
Human immune responses to live attenuated varicella vaccine.
Reviews of infectious diseases 1991;13 Suppl 11():S957-9.
1991: S P Steinberg; Anne A Gershon
Measurement of antibodies to varicella-zoster virus by using a latex agglutination test.
Journal of clinical microbiology 1991;29(7):1527-9.
1990: Anne A Gershon
Immunization practices in children.
Hospital practice (Office ed.) 1990;25(9):91-4, 97-103, 107.
1990: Philip S LaRussa; Anne A Gershon; S P Steinberg; S A Chartrand
Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children.
The Journal of infectious diseases 1990;162(3):627-33.
1990: Anne A Gershon
Viral vaccines of the future.
Pediatric clinics of North America 1990;37(3):689-707.
1990: Anne A Gershon; S P Steinberg
Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
The Journal of infectious diseases 1990;161(4):661-6.
1990: I R Hardy; Anne A Gershon
Prospects for use of a varicella vaccine in adults.
Infectious disease clinics of North America 1990;4(1):159-73.
1990: M Tsolia; Anne A Gershon; S P Steinberg; L Gelb
Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
The Journal of pediatrics 1990;116(2):184-9.
1989: C A Gabel; L Dubey; S P Steinberg; D Sherman; Michael D Gershon; Anne A Gershon
Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during posttranslational maturation.
Journal of virology 1989;63(10):4264-76.
1989: Margaret R Hammerschlag; Anne A Gershon; S P Steinberg; L Clarke; L D Gelb
Herpes zoster in an adult recipient of live attenuated varicella vaccine.
The Journal of infectious diseases 1989;160(3):535-7.
1989: Anne A Gershon; S P Steinberg
Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
The New England journal of medicine 1989;320(14):892-7.
1988: Anne A Gershon; S P Steinberg; Philip S LaRussa; A Ferrara; Margaret R Hammerschlag; L Gelb
Immunization of healthy adults with live attenuated varicella vaccine.
The Journal of infectious diseases 1988;158(1):132-7.
1988: L Dubey; S P Steinberg; Philip S LaRussa; P Oh; Anne A Gershon
Western blot analysis of antibody to varicella-zoster virus.
The Journal of infectious diseases 1988;157(5):882-8.
1987: L D Gelb; D E Dohner; Anne A Gershon; S P Steinberg; J L Waner; M Takahashi; Penelope Dennehy; Arthur E Brown
Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.
The Journal of infectious diseases 1987;155(4):633-40.
1986: Anne A Gershon; S P Steinberg; L Gelb
Live attenuated varicella vaccine use in immunocompromised children and adults.
Pediatrics 1986;78(4 Pt 2):757-62.
1985: D L Williams; Anne A Gershon; L D Gelb; M K Spraker; S Steinberg; A H Ragab
Herpes zoster following varicella vaccine in a child with acute lymphocytic leukemia.
The Journal of pediatrics 1985;106(2):259-61.
1985: Anne A Gershon; S Steinberg; L Gelb; G Galasso; W Borkowsky; Philip S LaRussa; A Ferrara
A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.
Postgraduate medical journal 1985;61 Suppl 4():73-8.
1984: Anne A Gershon; S Steinberg; G Galasso; W Borkowsky; Philip S LaRussa; A Ferrara; L Gelb
Live attenuated varicella vaccine in children with leukemia in remission.
Biken journal 1984;27(2-3):77-81.
1984: Anne A Gershon; S P Steinberg; L Gelb; G Galasso; W Borkowsky; Philip S LaRussa; A Farrara
Live attenuated varicella vaccine. Efficacy for children with leukemia in remission.
JAMA : the journal of the American Medical Association 1984;252(3):355-62.
1984: Anne A Gershon; S P Steinberg; L Gelb
Clinical reinfection with varicella-zoster virus.
The Journal of infectious diseases 1984;149(2):137-42.